Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2007-02-02
2010-02-23
Pak, Michael (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S130100, C424S133100, C424S142100, C424S145100, C514S002600, C514S008100, C530S350000, C530S387100, C530S395000, C435S069700, C435S325000, C435S375000
Reexamination Certificate
active
07666416
ABSTRACT:
The present invention relates to novel process for the preparation of glycoproteins by mammalian-cell culture wherein the sialic acid content of the glycoprotein' produced is controlled over a broad range of values by manipulating the cell culture environment. The invention provides for processes in which the sialic acid content of the glycoprotein is modified by changes in cell culture parameters which affect cell specific productivity. Preferred embodiments of the invention include cell culture processes in the osmolality of the cell culture is controlled as well as the concentration of a transcription enhancer during the production phase of the cell culture. The invention further provides for novel preparations of-soluble type 1 tumor necrosis factor immunoglobulin G1 and their uses in the treatment of inflammatory or immune related disorders.
REFERENCES:
patent: 4724206 (1988-02-01), Rupp et al.
patent: 5096816 (1992-03-01), Maiorella
patent: 5122469 (1992-06-01), Mather et al.
patent: 5151359 (1992-09-01), Miyahara et al.
patent: 5316938 (1994-05-01), Keen et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5510261 (1996-04-01), Goochee et al.
patent: 5705364 (1998-01-01), Etcheverry et al.
patent: 5721121 (1998-02-01), Etcheverry et al.
patent: 6656466 (2003-12-01), Etcheverry et al.
patent: 0 239 292 (1987-09-01), None
patent: 0307247 (1989-03-01), None
patent: 387840 (1990-09-01), None
patent: 0481791 (1992-04-01), None
patent: 2122207 (1984-01-01), None
patent: 2 153 830 (1985-08-01), None
patent: 2251249 (1992-07-01), None
patent: 1-257492 (1989-10-01), None
patent: 7-31495 (1995-02-01), None
patent: WO 89/04867 (1989-06-01), None
patent: WO 94/06476 (1994-03-01), None
Anderson, Dana C., et al., “Structures of Secreted Glycoproteins,” Biotechnology, 5: 546-549 (1994).
Carothers, Adelaide M., et al., “Splicing Mutants and Their Second-Site Suppressors at the Dihydrofolate Reductase Locus in Chinese Hamster Ovary Cells,” Molecular and Cellular Biology, 13(8): 5085-5098 (1993).
Conrad, Harald S., “Expression of Human Interleukin-2 in Recombinant Baby Hamster Kidney, Ltk—,and Chinese Hamster Ovary Cells,” The Journal of Biological Chemistry, 264(29): 17368-17373 (1989).
Gramer, Michael J., et al., “Extracellular CHO Cell Sialidase,” Biotechnology, 13: 692-698 (1995).
Gray, Peter P., et al., “Growth of a Recombinant Chinese Hamster Ovary Cell Line and High Level Expression in Protein Free Medium,” Trends in Animal Cell Culture Technology, 265-270 (1989).
Interlocutory Decision in Opposition Proceedings To European Patent No. EP 0 832 189 B1, Application No. 96918251.8, Oral Proceedings Date: Oct. 23, 2007.
Lucas, Brian K., et al., “High-Level Production of Recombinant Proteins in CHO Cells Using a Dicistronic DHFR Intron Expression Vector,” Nucleic Acids Research, 24(9): 1774-1779, (1996).
Maun, Henry R., “Disulfide Locked Variants of Factor VIIa with a Restricted β-strand Conformation Have Enhanced Enzymatic Activity,” Protein Science, 14: 1171-1180 (2005).
Mimura, Yusuke, et al., “Butyrate Increases Production of Human Chimeric IgG in CHO-K1 Cells Whilst Maintaining Function and Glycoform Profile,” Journal of Immunological Methods, 247: 205-216 (2001).
Moguilevsky, Nicole, et al., “Structural and Biological Properties of Human recombinant Myeloperoxidase Produced by Chinese Hamster Ovary Cell Lines,” Eur. J. Biochem., 197: 605-614 (1991).
Morser, J., et al., “Low Temperature Treatment of Namalwa Cells Causes Superproduction of Interferon,” J. Gen. Virol., 56: 163-174 (1981).
Musgrave, S.C., et al., “Optimisation of α-Interferon Expression of Namalwa Cells,” Animal Cell Technology: Basic & Applied Aspects, 5: 223-230 (1993).
Oh, Steve K.W., et al., “Substantial Overproduction of Antibodies by Applying Osmotic Pressure and Sodium Butyrate,” Biotechnology and Bioengineering, 42: 601-610 (1993).
Opposition to European Patent No. EP 0 832 189 B1 by GlaxoSmithKline Biologicals s.a., Application No. 96918251.8, Grant Date: Aug. 17, 2005.
Simonsen, Christian C., et al., “Isolation and Expression of an Altered Mouse Dihydrofolate Reductase cDNA,” Proc. Natl. Acad. Sci., 80: 2495-2499 (1983).
Sures, Irmi, et al., “Nucleotide Sequence of Human Preproinsulin Complementary DNA,” Science, 208: 57-59 (1980).
Utsumi, Jun, et al., “Characterization of Four Different Mammalian-Cell-Derived Recombinant Human Interferon-β1s,” Eur. J. Biochem., 181: 545-553 (1989).
Andersen et al., “The Effect of Ammonium Ion on the O-Linked Glycosylation of Granulocyte Colony-Stimulating Factor Produced by CHO Cells”Abstracts of Papers, American Chemical Societypp. 169 (1993).
Borys et al., “Ammonia Affects the Glycosylation Patterns of Recombinant Mouse Placental Lactogen-I By Chinese Hamster Ovary Cells in a pH-Dependent Manner”Biotechnology and Bioengineering43:505-514 (1994).
Borys et al., “Culture pH Affects Expression Rates and Glycosylation of Recombinant Mouse Placental Lactogen Proteins by Chinese Hamster Ovary (CHO) Cells”Bio/Technology11:720-724 (1993).
Chotigeat et al., “Role of Environmental Conditions on the Expression Levels, Glycoform Pattern and Levels of Sialytransferase for hFSH Produced by Recombinant CHO cells”Cytotechnology15:217-221 (1994).
Cox et al., “Effect of Media Composition on the Induction of Chorionic Gonadotropin by Sodium Butyrate in HeLa Cells” In Vitro 19(1):1-6 (1983).
Curling et al., “Recombinant Human IFN-γ Produced by CHO Cells: Effects of Culture Environment on Product Quality”Harnessing Biotechnology for the 21st Centurypp. 308-310 (1992).
D'Anna et al., “Concentration-Dependent Effects of Sodium Butyrate in Chinese Hamster Cells: Cell-Cycle Progression, Inner-Histone Acetylation, Histone H1 Dephosphorylation, and Induction of an H1-like Protein”Biochemistry19:2656-2671 (1980).
Engelmann et al., “Effect of Sodium Butyrate on Primary Cultures of Adult Rat Hepatocytes” In VitroCellular&Developmental Biology23(2):86-92 (1987).
Exley et al., “Monoclonal antibody to TNF in severe septic shock”Lancet335:1275-1276 (1990).
Forman et al., “Control of Osmolality in Mammalian Cell Cultures: Reduction of Lactic Acid Accumulation Throughout On-line Control of Glucose Concentration”Abstracts of Papers, American Chemical Society, 207th ACS National Meetingpp. 135 (1994).
Garcia-Perez et al., “Molecular Cloning of cDNA Coding for Kidney Aldose Reductase”Journal of Biological Chemistry264(28):16815-16821 (1989).
Gawlitzek et al., “Changes in the Glycosylation Pattern of Recombinant Proteins Effected by Defined Culture Conditions of BHK-21 Cells”Animal Cell Technologypp. 649-651 (1989).
Goochee et al., “Bioprocess Factors Affecting Glycoprotein Oligosaccharide Structure”DNA and Cell Biology76:95-104 (1992).
Goochee et al., “Environmental Effects on Protein Glycosylation”Bio/Technology8:421-427 (1990).
Goochee et al., “The Oligosaccarides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and Their Effect on Glycoprotein Properties”Bio/Technology9:1347-1355 (1991).
Goochee et al., “The Oligosaccharides of Glycoproteins: Factors Affecting Their Synthesis and Their Influence on Glycoprotein Properties”Frontiers in Bioprocessing IIpp. 199-240 (1992).
Gorman et al., “Expression of Recombinant Plasmids in Mammalian Cells is Enhanced by Sodium Butyrate”Nucleic Acids Research11(21):7631-7648 (1983).
Gramer et al., “Potential for degradation of glycoprotein oligosaccharides by extracellular glycosidases”Am. Chem. Soc. (Abstract, 203rd Meeting, San Francisco, CA) PT 1:BIOT-71 (Apr. 5, 1992).
Hagopian et al., “Effect of n-Butyrate on DNA Synthesis in Chick Fibrob
Etcheverry Tina
Ryll Thomas
Arnold & Porter LLP
Dreger, Esq. Ginger R.
Genentech Inc.
Kubinec, Esq. Jeffrey
Pak Michael
LandOfFree
Mammalian cell culture process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mammalian cell culture process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mammalian cell culture process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4233029